Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 4
1980 6
1981 3
1982 7
1983 6
1984 2
1985 9
1986 10
1987 20
1988 16
1989 15
1990 25
1991 27
1992 35
1993 45
1994 57
1995 71
1996 92
1997 104
1998 86
1999 122
2000 126
2001 163
2002 179
2003 187
2004 237
2005 283
2006 347
2007 418
2008 539
2009 582
2010 754
2011 898
2012 1066
2013 1370
2014 1623
2015 1931
2016 2052
2017 2411
2018 2728
2019 3261
2020 4054
2021 4895
2022 5982
2023 5909
2024 2342

Text availability

Article attribute

Article type

Publication date

Search Results

40,078 results

Results by year

Filters applied: . Clear all
Page 1
Targeting PRMT9-mediated arginine methylation suppresses cancer stem cell maintenance and elicits cGAS-mediated anticancer immunity.
Dong H, He X, Zhang L, Chen W, Lin YC, Liu SB, Wang H, Nguyen LXT, Li M, Zhu Y, Zhao D, Ghoda L, Serody J, Vincent B, Luznik L, Gojo I, Zeidner J, Su R, Chen J, Sharma R, Pirrotte P, Wu X, Hu W, Han W, Shen B, Kuo YH, Jin J, Salhotra A, Wang J, Marcucci G, Luo YL, Li L. Dong H, et al. Among authors: zhu y. Nat Cancer. 2024 Feb 27. doi: 10.1038/s43018-024-00736-x. Online ahead of print. Nat Cancer. 2024. PMID: 38413714
Interleukin-6 classic and trans-signaling utilize glucose metabolism reprogramming to achieve anti- or pro-inflammatory effects.
Xu S, Deng KQ, Lu C, Fu X, Zhu Q, Wan S, Zhang L, Huang Y, Nie L, Cai H, Wang Q, Zeng H, Zhang Y, Wang F, Ren H, Chen Y, Yan H, Xu K, Zhou L, Lu M, Zhu Y, Liu S, Lu Z. Xu S, et al. Among authors: zhu y. Metabolism. 2024 Mar 2;155:155832. doi: 10.1016/j.metabol.2024.155832. Online ahead of print. Metabolism. 2024. PMID: 38438106
Targeting pro-inflammatory T cells as a novel therapeutic approach to potentially resolve atherosclerosis in humans.
Fan L, Liu J, Hu W, Chen Z, Lan J, Zhang T, Zhang Y, Wu X, Zhong Z, Zhang D, Zhang J, Qin R, Chen H, Zong Y, Zhang J, Chen B, Jiang J, Cheng J, Zhou J, Gao Z, Liu Z, Chai Y, Fan J, Wu P, Chen Y, Zhu Y, Wang K, Yuan Y, Huang P, Zhang Y, Feng H, Song K, Zeng X, Zhu W, Hu X, Yin W, Chen W, Wang J. Fan L, et al. Among authors: zhu y. Cell Res. 2024 Mar 15. doi: 10.1038/s41422-024-00945-0. Online ahead of print. Cell Res. 2024. PMID: 38491170
Transketolase promotes MAFLD by limiting inosine-induced mitochondrial activity.
Tong L, Chen Z, Li Y, Wang X, Yang C, Li Y, Zhu Y, Lu Y, Liu Q, Xu N, Shao S, Wu L, Zhang P, Wu G, Wu X, Chen X, Fang J, Jia R, Xu T, Li B, Zheng L, Liu J, Tong X. Tong L, et al. Among authors: zhu y. Cell Metab. 2024 Mar 23:S1550-4131(24)00082-2. doi: 10.1016/j.cmet.2024.03.003. Online ahead of print. Cell Metab. 2024. PMID: 38547864
40,078 results
You have reached the last available page of results. Please see the User Guide for more information.